Weinstein, Rachel B. http://orcid.org/0000-0002-0023-9578
Ryan, Patrick
Berlin, Jesse A.
Matcho, Amy
Schuemie, Martijn
Swerdel, Joel
Patel, Kayur
Fife, Daniel
Funding for this research was provided by:
No sources of funding were used to conduct this study or prepare this manuscript
Article History
First Online: 5 August 2017
Compliance with Ethical Standards
:
: No sources of funding were used to conduct this study or prepare this manuscript. Janssen Research and Development is the sponsor of Open Access.
: Jesse A. Berlin, Daniel Fife, Amy Matcho, Kayur Patel, Martijn Schuemie, Joel Swerdel, Patrick Ryan, and Rachel Weinstein were full-time employees of Johnson & Johnson, or a subsidiary, at the time the study was conducted. Johnson & Johnson manufactures several medications that contain paracetamol or ibuprofen. Jesse A. Berlin, Daniel Fife, Amy Matcho, Kayur Patel, Martijn Schuemie, Joel Swerdel, Patrick Ryan, and Rachel Weinstein own stock, stock options and pension rights from the company.
: This study is based on data from the CPRD obtained under license from the UK Medicines and Healthcare products RegulatoryAgency. The protocol for this study is available at ClinicalTrials.gov (NCT identifier: NCT02830178) and was approved by the data provider’s ISAC (protocol 15_173R).